Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-23T12:17:50.607Z Has data issue: false hasContentIssue false

Endogenous Digoxin-Like Factor: Possible Emergency Implications

Published online by Cambridge University Press:  28 June 2012

Alexey Ya Bagrov
Affiliation:
Coronary Care Unit, I.I.Dzhanelidze First Aid Research Institute, and Laboratory of Physiology and Laboratory of Pharmacology, I. M Sechenov Institute of Evolutionary Physiology and Biochemistry, Academy of Sciences, USSR, Leningrad, USSR

Summary

The existence of endogenously produced, digoxin-like factor(s) is clear. The implications of die presence of this circulating substance are substantial for the practice of emergency medical care. Clearly, EDLF plays an important role in the generation of dysrhythmias associated with an AMI. Treatment with AA could become routine early in the course of management of some patients with AMI and in die treatment of some forms of hypertension

Type
Special Report
Copyright
Copyright © World Association for Disaster and Emergency Medicine 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Gruber, KA: Perspect Bid Med 1982;26:5161.CrossRefGoogle Scholar
2. Rein, H: Über ein regulationssystem “Milz-leber” fur den oxydativen stroffwechsel der Körperqewebe und besonders des Herzens. Naturwissenschaften 1949;36:233239.CrossRefGoogle Scholar
3. Szent-Gyorgyi, A: Chemical Physiology of Contraction in Body and Heart Muscle. New York, 1952.Google Scholar
4. de Wardener, HE, Clarkson, EN: Concept of natriuretic hormone. Physiol Rev 1985;65:758759.CrossRefGoogle ScholarPubMed
5. Gonick, HC, Kramer, HJ, Paul, W, Lu, E: Circulating inhibitor of sodium potassium-activated adenosine triphoshate after expansion of extra cellular fluid volume in rats. Clin Sci Mol Med 1977, 53:329334.Google Scholar
6. Gruber, KA, Whitaker, JM, Bucklew, VM Jr: Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature (London) 1980;287:743745.CrossRefGoogle ScholarPubMed
7. Cloix, JF: Endogenous digitalislike compounds. A tentative update of chemical and biological studies. Hypertension 1987;10 (Suppl I):167170.Google Scholar
8. Gonick, HC: in Endocrine Regulation of Electrolyte Balance, ed. by Krück, F, and Thurau, K, Berlin, 1986.Google Scholar
9. La Bella, F, Bihler, I, Templeton, J et al. : Progesterone derivatives that bind to the digitalis receptor: Effects on Na+,K+-ATPase and isolated tissues. Federation Proc 1985;44:28062811.Google Scholar
10. Haddy, FJ, Pamnani, MB: Evidence for a circulating endogenous Na+-K+ pump inhibitor in low-renin hypertension. Federation Proc 1985;44:27892794.Google ScholarPubMed
11. Blaustein, MP, Ashida, T, Hamlyn, JM: Sodium metabolism and hypertension: How are they linked? Klin Wochenschr 1987;65 (Suppl. VIII):2132.Google ScholarPubMed
12. Abbot, A: Trends Pharmacol Sci 1988;9:111113.CrossRefGoogle Scholar
13. Clough, DL, Huot, SJ, Pamnani, MB, Haddy, FJ: Decreased myocardial Na+K+ATPase activity in rats with reduced renal mass-saline hypertension. J Hypertens 1985;3:583589.CrossRefGoogle ScholarPubMed
14. Schreiber, V, Kolbel, F, Stepan, J et al. : Digoxin-like immunoreactivity in the serum of rats with cardiac overload. J Molec Cell Cardiol 1981;13:107110.CrossRefGoogle ScholarPubMed
15. Delva, P, Devynck, MA, Degan, M et al. : Correlations between plasma levels of a endogenous digitalis-tike substance and haemodynamic parameters measured during cardiac catheterization. J Hypertens 1988;6(Suppl. 4):S348–S350.CrossRefGoogle ScholarPubMed
16. Smith, TW, Barry, WH: Curr Top Membr Transp 1983;19:857884.CrossRefGoogle Scholar
17. Verrier, RL, Lown, B: Neural influences and sudden cardiac death. Adv Cardiol (Basel) 1978;25:155168.CrossRefGoogle ScholarPubMed
18. Kim, DH, Akera, T, Weaver, LC: Role of sympathetic nervous system in ischemia-induced reduction of digoxin tolerance in anesthetized cats. J Pharm Exp. Ther 1983;228:537544.Google Scholar
19. Maixent, JM, Lelievre, LG: Differential activation of inotropic and toxic digitalis receptors in ischemic dog heart: Molecular basis of the deleterious effects of digitalis. J Biol Chem 1987;262:1245812462.CrossRefGoogle Scholar
20. Kunes, J, Stolba, P, Pohlova, et al. : The importance of endogenous digoxin-like factors in rats with various forms of hypertension. Clin Exp Hypertens 1985;(A)7:707720.Google Scholar
21. Bagrov, AYa, Ganelina, IE, Nikiforova, KA et al. : (in Russian), in Proceedings of the Conference “Diagnosis and Treatment of Myocardial Infarction,” Tbilisi, June 1987, pp 177180.Google Scholar
22. Walter, U, Muller, S: Evidence for Na+K+ATPase inhibitor in erythrocytes of patients with essential hypertension. Europ.J Clin Invest 1985;15:209214.CrossRefGoogle ScholarPubMed
23. Kazennov, AM, Maslova, MN, Shalabodov, AD et al. : Some properties of erythrocyte Na+ K+-ATPase in essential hypertension. Clin Exp Hypertens 1987;(A)7:12211232.Google Scholar
24. Bagrov, A Ya, Fedorova, OV, Maslova, MN et al. : Antiarrythmic effect of antibodies to digoxin in acute myocardial ischemia in rats. Europ J Pharm 1989;162:195196.CrossRefGoogle Scholar
25. Bagrov, A Ya, Zhabko, EP, Maslova, MN et al. : Rat' endogennogo digoksinopodobnogo faktora v reguliatsiikrovodorashcheniia i proiskhozhdenii aritmii pri ischemii miokarda (in Russian). Terapevt Arkh 1989;61:8489.Google Scholar
26. Smith, TW, Butler, VP, Haber, E et al. : Treatnment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: Experience in 26 cases. N Engl J Med 1982;307:13571362.CrossRefGoogle Scholar
27. Simonia, GV, Tatishvili, NI, Anjaparidze, KL et al. : Procedings. Seminar Congestive Heart Failure. Tbilisi, October, 1989.Google Scholar
28. Graves, SW, Williams, GH: Endogenous digitalis-like natriuretic factors. Annu Rev Med 1987;38:433444.CrossRefGoogle ScholarPubMed